Warwick J. Locke

1.4k citations

13 papers · 773 indexed · 1 hit paper · h-index 11

Co-authors: Jason P. Ross Chenkai Ma Kim Y. C. Fung Konsta Duesing Dominic Guanzon Yi Jin Liew Susan J. Clark Clare Stirzaker
Topics: Epigenetics and DNA Methylation (8 papers)Genomics and Chromatin Dynamics (6 papers)RNA modifications and cancer (4 papers)
Cited by: Cancer Research Molecular Biology Oncology
Journals: Nature Communications Oncogene Scientific Reports
Partner nations: Australia United Kingdom Spain

In The Last Decade

Warwick J. Locke

13 papers receiving 771 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

DNA Methylation Cancer Biomarkers: Translation to the Clinic

2019 317 citations Warwick J. Locke, Dominic Guanzon et al. Frontiers in Genetics profile →

Peers

Countries citing papers authored by Warwick J. Locke

Since Specialization

Citations

This map shows the geographic impact of Warwick J. Locke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Warwick J. Locke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Warwick J. Locke more than expected).

Fields of papers citing papers by Warwick J. Locke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Warwick J. Locke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Warwick J. Locke. The network helps show where Warwick J. Locke may publish in the future.

Co-authorship network of co-authors of Warwick J. Locke

This figure shows the co-authorship network connecting the top 25 collaborators of Warwick J. Locke. A scholar is included among the top collaborators of Warwick J. Locke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Warwick J. Locke. Warwick J. Locke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Epigenetic liquid biopsies for minimal residual disease, what’s around the corner? 2023 ·Frontiers in Oncology ·(unknown),Jason P. Ross,Chenkai Ma,Kim Y. C. Fung,Warwick J. Locke	14
2	Next-Generation Molecular Discovery: From Bottom-Up In Vivo and In Vitro Approaches to In Silico Top-Down Approaches for Therapeutics Neogenesis 2022 ·Life ·(unknown),Fiach Antaw,Warwick J. Locke,Christopher B. Howard,Darren Korbie,Matt Trau	2
3	Identification of DNA methylation biomarkers with potential to predict response to neoadjuvant chemotherapy in triple-negative breast cancer 2021 ·Clinical Epigenetics ·(unknown),(unknown),Warwick J. Locke,Phuc‐Loi Luu,Qian Du,(unknown),Nicola J. Armstrong,Beena Kumar,Niantao Deng,Kate Harvey,Alexander Swarbrick,Vinod Ganju,Susan J. Clark,Ruth Pidsley,Clare Stirzaker	19
4	Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine-resistant breast cancer 2020 ·Nature Communications ·Joanna Achinger-Kawecka,Fátima Valdés‐Mora,Phuc‐Loi Luu,Katherine A. Giles,C. Elizabeth Caldon,Wenjia Qu,Shalima S. Nair,Sebastián Ventura,Warwick J. Locke,Nicole Shu Ling Yeo-Teh,Cathryn M. Gould,Qian Du,Grady C. Smith,(unknown),(unknown),Dave S.�B. Hoon,Julia M.W. Gee,Clare Stirzaker,Susan J. Clark	96
5	DNA Methylation Cancer Biomarkers: Translation to the Clinicbreakdown → 2019 ·Frontiers in Genetics ·Warwick J. Locke,Dominic Guanzon,Chenkai Ma,Yi Jin Liew,Konsta Duesing,Kim Y. C. Fung,Jason P. Ross	317
6	Clinical relevance of the transcriptional signature regulated by CDC42 in colorectal cancer 2017 ·Oncotarget ·Fátima Valdés‐Mora,Warwick J. Locke,Eva Bandrés,David Gallego‐Ortega,Paloma Cejas,Miguel Ángel García‐Cabezas,Yolanda Colino‐Sanguino,Jaime Feliú,Teresa Gómez del Pulgar,Juan Carlos Lacal	12
7	Methyl-CpG-binding protein MBD2 plays a key role in maintenance and spread of DNA methylation at CpG islands and shores in cancer 2016 ·Oncogene ·Clare Stirzaker,Jenny Z. Song,Wai Tong Ng,Qian Du,Nicola J. Armstrong,Warwick J. Locke,Aaron L. Statham,Hugh J. French,Ruth Pidsley,Fátima Valdés‐Mora,Elena Zotenko,Susan J. Clark	56
8	DNA methylation profile of triple negative breast cancer-specific genes comparing lymph node positive patients to lymph node negative patients 2016 ·Scientific Reports ·Andrea Mathe,Michelle W. Wong‐Brown,Warwick J. Locke,Clare Stirzaker,Stephen Braye,John Forbes,Susan J. Clark,Kelly A. Avery‐Kiejda,Rodney J. Scott	33
9	Coordinated epigenetic remodelling of transcriptional networks occurs during early breast carcinogenesis 2015 ·Clinical Epigenetics ·Warwick J. Locke,Elena Zotenko,Clare Stirzaker,Mark D. Robinson,Rebecca A. Hinshelwood,Andrew Stone,Roger R. Reddel,Lily I. Huschtscha,Susan J. Clark	24
10	DNA methylation of oestrogen-regulated enhancers defines endocrine sensitivity in breast cancer 2015 ·Nature Communications ·Andrew Stone,Elena Zotenko,Warwick J. Locke,Darren Korbie,Ewan K.A. Millar,Ruth Pidsley,Clare Stirzaker,Peter Graham,Matt Trau,Elizabeth A. Musgrove,(unknown),Julia M.W. Gee,Susan J. Clark	101
11	Epigenome remodelling in breast cancer: insights from an early in vitro model of carcinogenesis 2012 ·Breast Cancer Research ·Warwick J. Locke,Susan J. Clark	30
12	A role for GATA-2 in transition to an aggressive phenotype in prostate cancer through modulation of key androgen-regulated genes 2009 ·Oncogene ·Maret Böhm,Warwick J. Locke,R. Sutherland,James G. Kench,Susan M. Henshall	68
13	Hyperthyroidism in the aged. 1967 ·PubMed ·Warwick J. Locke	1

About Warwick J. Locke

Warwick J. Locke is a scholar working on Cancer Research, Molecular Biology and Biotechnology, having authored 13 papers that have together received 773 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (8 papers), Genomics and Chromatin Dynamics (6 papers) and RNA modifications and cancer (4 papers). The work is most often cited by research in Cancer Research (283 citations), Molecular Biology (604 citations) and Oncology (128 citations). Warwick J. Locke has collaborated with scholars based in Australia, United Kingdom and Spain. Frequent co-authors include Jason P. Ross, Chenkai Ma, Kim Y. C. Fung, Konsta Duesing, Dominic Guanzon, Yi Jin Liew, Susan J. Clark, Clare Stirzaker, Elena Zotenko and Ruth Pidsley. Their work appears in journals such as Nature Communications, Oncogene and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact